Aggregate-data estimation of an individual patient data linear random effects meta-analysis with a patient covariate-treatment interaction term.

Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. Arthritis Res Ther (2015) 0.92

The role of environmental heterogeneity in meta-analysis of gene-environment interactions with quantitative traits. Genet Epidemiol (2014) 0.86

Effects of exercise on BMI z-score in overweight and obese children and adolescents: a systematic review with meta-analysis. BMC Pediatr (2014) 0.82

Efficient Estimation of the Cox Model With Auxiliary Subgroup Survival Information. J Am Stat Assoc (2016) 0.75

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Random-effects models for longitudinal data. Biometrics (1982) 54.17

Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11

Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med (2000) 11.03

How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet (2005) 5.94

The challenge of subgroup analyses--reporting without distorting. N Engl J Med (2006) 4.19

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess (2001) 3.32

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol (2002) 2.57

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation (1995) 2.15

Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics (1998) 2.11

On the relative efficiency of using summary statistics versus individual-level data in meta-analysis. Biometrika (2010) 2.06

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol (2004) 2.02

Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data. Stat Med (2007) 1.74

Maximum-likelihood estimation for the mixed analysis of variance model. Biometrika (1967) 1.74

Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol (2007) 1.71

Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. J Clin Epidemiol (2011) 1.40

On the equivalence of meta-analysis using literature and using individual patient data. Biometrics (1999) 1.24

Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. Int J Technol Assess Health Care (2008) 0.93

Survey finds that most meta-analysts do not attempt to collect individual patient data. J Clin Epidemiol (2012) 0.83

Using aggregate data to estimate the standard error of a treatment-covariate interaction in an individual patient data meta-analysis. Biom J (2012) 0.77